Since 1939, the use of heparin has become widespread in the prevention of postoperative thrombosis and embolism and is the basis for modern open-heart surgery. What is not generally known is the story of Jay McLean, the second-year medical student at Johns Hopkins who is given credit for the original discovery. McLean\u27s first scientific publication concerning the use of heparin does not contain the word heparin, and not until 25 years later did McLean publish a short paper about heparin. Some personal letters and other research have indicated a checkered career. He was trained as a surgeon in the Halsted school but was practicing therapeutic radiology when he died in Savannah in 1957
AbstractHeparin-induced thrombocytopenia is a rare but serious complication of heparin therapy. Most...
Vitamin K, heparin and their antagonists remain the basis of coagulation therapies today, more than ...
The antithrombotic action of a heparin is not necessarily confined to its effects on the clotting me...
The discovery of heparin in 1916 by Jay McLean, a medical student at Johns Hopkins University, not o...
© 2017 Future Medicine Ltd. Heparin is one of the oldest drugs, which nevertheless remains in widesp...
The discovery of heparin dates back to 1916. In 2016, there will be the hundredth anniversary since ...
Heparin has been used as an anticoagulant for over 75 years since it entered clinical trials in 1935...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/97239/1/j.1552-4604.1979.tb02490.x.pd
Modern doctors and their patients whose lives depend on therapies used routinely in cardiovascular a...
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a...
A heightened risk of thrombosis noted early on with the severe acute respiratory syndrome coronaviru...
AbstractOn the centenary of the discovery of heparin, the International Journal of Cardiology agreed...
Heparin was discovered around 1922 by Howell (Baltimore) and was further developed by the teams of B...
The anticlotting and antithrombotic activities of heparin, heparan sulfate, low molecular weight hep...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90371/1/j.1875-9114.1996.tb02981.x.pd
AbstractHeparin-induced thrombocytopenia is a rare but serious complication of heparin therapy. Most...
Vitamin K, heparin and their antagonists remain the basis of coagulation therapies today, more than ...
The antithrombotic action of a heparin is not necessarily confined to its effects on the clotting me...
The discovery of heparin in 1916 by Jay McLean, a medical student at Johns Hopkins University, not o...
© 2017 Future Medicine Ltd. Heparin is one of the oldest drugs, which nevertheless remains in widesp...
The discovery of heparin dates back to 1916. In 2016, there will be the hundredth anniversary since ...
Heparin has been used as an anticoagulant for over 75 years since it entered clinical trials in 1935...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/97239/1/j.1552-4604.1979.tb02490.x.pd
Modern doctors and their patients whose lives depend on therapies used routinely in cardiovascular a...
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a...
A heightened risk of thrombosis noted early on with the severe acute respiratory syndrome coronaviru...
AbstractOn the centenary of the discovery of heparin, the International Journal of Cardiology agreed...
Heparin was discovered around 1922 by Howell (Baltimore) and was further developed by the teams of B...
The anticlotting and antithrombotic activities of heparin, heparan sulfate, low molecular weight hep...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90371/1/j.1875-9114.1996.tb02981.x.pd
AbstractHeparin-induced thrombocytopenia is a rare but serious complication of heparin therapy. Most...
Vitamin K, heparin and their antagonists remain the basis of coagulation therapies today, more than ...
The antithrombotic action of a heparin is not necessarily confined to its effects on the clotting me...